The New York Times article “Drug Shortages Near an All-Time High, Leading to Rationing” addresses the growing concern of patients facing treatment delays due to drug shortages. Sardella, who appeared before the House Energy and Commerce Committee last Thursday, was quoted in the article, “but there is a high cost to low prices,” when presenting how generic drug prices have fallen in recent years and how reduced earnings may lead to quality problems.

To learn more about these drug shortages, read the New York Times article.